Events

Scientist.com recently qualified our SRM and TMT-SRM essays as being fit-for purpose under GCLP accreditation

Proteome Sciences plc is pleased to be attending and presenting at Biomarkers UK to be held on the 3 and 4 May 2022 in London, UK.

We are attending this event as an exhibitor and delegate and look forward to meeting you all.

To request a meeting please click here

Meeting Summary:  During this 4th edition participants will be able to discover the latest research developments from renowned academic presenters, while also coming into contact with disruptive technology platforms from industry. Over 30 speakers will present their work in sessions focussing on:

• Single cell and spatial proteomics
• Computational proteomics
• Clinical proteomics
• Single molecule peptide analysis
• Biophysical characterization
• Structural proteomics

We are attending this event as a delegate and look forward to meeting you all.

To request a meeting please click here

We are attending this event as a delegate and look forward to meeting you all.

To request a meeting please click here

Meeting Summary:  The 5^th Single Cell Proteomics Conference (SCP2022) will be in Boston, USA. It will include virtual components via Zoom and a YouTube broadcast.

• The in-person meeting will be at Northeastern University in the John D. O’Bryant building, 1st floor (40 Leon Street). To cover the expenses for meals, it charges a registration fee. Attendance is limited to 150 participants.
• The virtual components are free of charge but require a registration and are limited to the first 3,000 attendees who sign up.

We are attending this event as an exhibitor, delegate and as a presenter.  We look forward to meeting you all.

To request a meeting please click here

Meeting Summary:  Leveraging next gen technologies beyond conventional biomarker drug discovery.  The 7th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference scheduled to be held on 16th - 17th June 2022 in San Diego, CA would address the gaps between early stage biomarker development and the commercialization stage of biomarkers.

Presentation Title: Enhanced Biomarker Discovery and Validation Using TMT^® Proteomics